Transferrin receptors in human tissues: their distribution and possible clinical relevance.

K C Gatter, G Brown, I S Trowbridge, R E Woolston, D Y Mason

The distribution of transferrin receptors (TR) has been studied in a range of normal and malignant tissues using four monoclonal antibodies, BK19.9, B3/25, T56/14 and T58/1. In normal tissues TR was found in a limited number of sites, notably basal epidermis, the endocrine pancreas, hepatocytes, Kupffer cells, testis and pituitary. This restricted pattern of distribution may be relevant to the characteristic pattern of iron deposition in primary haemachromatosis. In contrast to this limited pattern of expression in normal tissue, the receptor was widely distributed in carcinomas, sarcomas and in samples from cases of Hodgkin's disease. This malignancy-associated expression of the receptor may play a role in the anaemia of advanced malignancy by competing with the bone marrow for serum iron.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Radoshitzky, S. R., Kuhn, J. H., Spiropoulou, C. F., Albarino, C. G., Nguyen, D. P., Salazar-Bravo, J., Dorfman, T., Lee, A. S., Wang, E., Ross, S. R., Choe, H., Farzan, M. (2008). Receptor determinants of zoonotic transmission of New World hemorrhagic fever arenaviruses. Proc. Natl. Acad. Sci. USA 105: 2664-2669 [Abstract] [Full Text]  
• Heidel, J. D., Yu, Z., Liu, J. Y.-C., Rele, S. M., Liang, Y., Zeidan, R. K., Kornbrust, D. J., Davis, M. E. (2007). Inaugural Article: Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA. Proc. Natl. Acad. Sci. USA 104: 5715-5721 [Abstract] [Full Text]  
• Fernandez-Real, J. M., Moreno, J. M., Lopez-Bermejo, A., Chico, B., Vendrell, J., Ricart, W. (2007). Circulating Soluble Transferrin Receptor According to Glucose Tolerance Status and Insulin Sensitivity. Diabetes Care 30: 604-608 [Abstract] [Full Text]  
• Lepelletier, Y., Camara-Clayette, V., Jin, H., Hermant, A., Coulon, S., Dussiot, M., Arcos-Fajardo, M., Baude, C., Canionni, D., Delarue, R., Brousse, N., Benaroch, P., Benhamou, M., Ribrag, V., Monteiro, R. C., Moura, I. C., Hermine, O. (2007). Prevention of Mantle Lymphoma Tumor Establishment by Routing Transferrin Receptor toward Lysosomal Compartments. Cancer Res. 67: 1145-1154 [Abstract] [Full Text]  
• Zhang, D., Meyron-Holtz, E., Rouault, T. A. (2007). Renal Iron Metabolism: Transferrin Iron Delivery and the Role of Iron Regulatory Proteins. J. Am. Soc. Nephrol. 18: 401-406 [Full Text]  
• Karagiannis, T. C., Lobachevsky, P. N., Leung, B. K.Y., White, J. M., Martin, R. F. (2006). Receptor-Mediated DNA-Targeted Photoimmunotherapy. Cancer Res. 66: 10548-10552 [Abstract] [Full Text]  
• Brookes, M J, Hughes, S, Turner, F E, Reynolds, G, Sharma, N, Ismail, T, Berx, G, McKie, A T, Hotchin, N, Anderson, G J, Iqbal, T, Tselepis, C (2006). Modulation of iron transport proteins in human colorectal carcinogenesis. Gut 55: 1449-1460 [Abstract] [Full Text]  
• O'Donnell, K. A., Yu, D., Zeller, K. I., Kim, J.-w., Racke, F., Thomas-Tikhonenko, A., Dang, C. V. (2006). Activation of Transferrin Receptor 1 by c-Myc Enhances Cellular Proliferation and Tumorigenesis.. Mol. Cell. Biol. 26: 2373-2386 [Abstract] [Full Text]  
• Jones, D. T., Trowbridge, I. S., Harris, A. L. (2006). Effects of transferrin receptor blockade on cancer cell proliferation and hypoxia-inducible factor function and their differential regulation by ascorbate.. Cancer Res. 66: 2749-2756 [Abstract] [Full Text]  
• Hu-Lieskovan, S., Heidel, J. D., Bartlett, D. W., Davis, M. E., Triche, T. J. (2005). Sequence-Specific Knockdown of EWS-FLI1 by Targeted, Nonviral Delivery of Small Interfering RNA Inhibits Tumor Growth in a Murine Model of Metastatic Ewing's Sarcoma. Cancer Res. 65: 8984-8992 [Abstract] [Full Text]  
• Moura, I. C., Lepelletier, Y., Arnulf, B., England, P., Baude, C., Beaumont, C., Bazarbachi, A., Benhamou, M., Monteiro, R. C., Hermine, O. (2004). A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients. Blood 103: 1838-1845 [Abstract] [Full Text]  
• Ng, P. P., Dela Cruz, J. S., Sorour, D. N., Stinebaugh, J. M., Shin, S.-U., Shin, D. S., Morrison, S. L., Penichet, M. L. (2002). An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells. Proc. Natl. Acad. Sci. USA 99: 10706-10711 [Abstract] [Full Text]  
• SATO, Y., YAMAUCHI, N., TAKAHASHI, M., SASAKI, K., FUKAURA, J., NEDA, H., FUJII, S., HIRAYAMA, M., ITOH, Y., KOSHITA, Y., KOGAWA, K., KATO, J., SAKAMAKI, S., NIITSU, Y. (2000). In vivo gene delivery to tumor cells by transferrin-streptavidin-DNA conjugate. FASEB J. 14: 2108-2118 [Abstract] [Full Text]  
• Ali, S. A., Joao, H. C., Hammerschmid, F., Eder, J., Steinkasserer, A. (1999). Transferrin Trojan Horses as a Rational Approach for the Biological Delivery of Therapeutic Peptide Domains. J. Biol. Chem. 274: 24066-24073 [Abstract] [Full Text]  
• Bernstein, L. R. (1998). Mechanisms of Therapeutic Activity for Gallium. Pharmacol. Rev. 50: 665-682 [Abstract] [Full Text]  
• Guiang, S. F. III, Georgieff, M. K., Lambert, D. J., Schmidt, R. L., Widness, J. A. (1997). Intravenous iron supplementation effect on tissue iron and hemoproteins in chronically phlebotomized lambs. Am. J. Physiol. Regul. Integr. Comp. Physiol. 273: R2124-R2131 [Abstract] [Full Text]